Published on 23 Apr 2024 on Seeking Alpha
ImmunityBio stock jumps as FDA clears bladder cancer therapy (NASDAQ:IBRX)
Shares of ImmunityBio (IBRX) surged 33% premarket after FDA clearance of its combination therapy for...
NASDAQ.IBRX price evolution
Want to become a better investor?
Start tracking your investments with Statfolio
Sign up for free